PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
Key Financials
Gross Profit
$24541
0.0%
Net Income
$-5430851
↓ 14.8%
Operating Income
$-5294765
↓ 16.8%
Revenue
$336108
↓ 45.5%
Total Assets
$697502.00
↓ 30.7%
EPS (Diluted)
$-0.01
0.0%
Total Liabilities
$7.0M
↑ 0.4%
Shareholders' Equity
$-6298737.00
↓ 5.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/2/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PVCT |
| Company Name | PROVECTUS BIOPHARMACEUTICALS, INC. |
| CIK | 315545 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (866) 594-5999 |